Sara Torres-Esquius

5PUBLICATIONS
42CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Gene mappingPredictive and prognostic markersHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 15, 2026
Promoter TERT-Related Hematopoietic Somatic Mosaicism in Patients With Telomere Biology Disorders.

|Apr 09, 2026
Performance and clinical utility of Spanish germ line genetic testing criteria for hematologic neoplasms predisposition.

Sara Torres-Esquius, Guillermo Ramil, Maria Gabarrós-Subirà

|Dec 03, 2025
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study.

Carmelo Gurnari, Hideki Makishima, Arda Durmaz

|Apr 19, 2024
Germline assessment for alloHSCT candidates over 50 years: A 'Fast-Track' screening in myeloid neoplasms.

Sara Torres-Esquius, Francisco Beas, Tzu Hua Chen-Liang

|Mar 21, 2024
Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing.

Alejandra Rezqallah, Sara Torres-Esquius, Alba Llop-Guevara

Pageof 1

Frequent Collaborators

2 joint publications

Maria Julia Montoro

1 joint publications

Alejandra Rezqallah

1 joint publications

Alba Llop-Guevara

1 joint publications

María T Martinez